
Michael Sweet
Preclinical study management leader in cardiovascular and cell therapy
Summary
Work
Education
Projects
Writing
Five Costly Misconceptions About GLP Studies (And Why They Matter)
January 14, 2026A practitioner-focused blog post discussing common misunderstandings about GLP preclinical studies and guidance for planning and executing regulatory-grade preclinical work.
Sentry Bioconvertible Inferior Vena Cava Filter: Study of Stages of Incorporation in an Experimental Ovine Model
January 1, 2018Evaluation of the Sentry IVC filter in an ovine model, assessing deployment success, stages of bioconversion and incorporation into the vessel wall, and device-related outcomes through 180 days.
AN ENDOVASCULAR MODEL OF ISCHEMIC MYOPATHY FROM PERIPHERAL ARTERY DISEASE
January 1, 2016Describes an endovascular technique to produce a durable large-animal model of ischemic myopathy suitable for testing novel therapeutics for PAD and CLI.
Therapeutic potential of sustained-release sodium nitrite for critical limb ischemia in the setting of metabolic syndrome
January 1, 2015Investigation of a novel sustained-release sodium nitrite formulation in an Ossabaw swine model of CLI and metabolic syndrome, reporting cytoprotective and proangiogenic signaling in ischemic tissues.
Hemodynamic comparison of mitral valve repair: techniques for a flail anterior leaflet
January 1, 2014In-vitro experimental comparison of three surgical repair techniques (neochordoplasty, limited triangular resection, edge-to-edge repair) for anterior leaflet flail, quantifying hemodynamic and echocardiographic indices.
Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease
January 1, 2014Study of a sustained-release nitrite formulation that increased myocardial nitrite levels, reduced oxidative stress, and improved coronary vascular function in an obese porcine model with peripheral vascular disease.